Traditional Chinese medicine composition for resisting oxidation and assisting in reducing blood sugar as well as preparation method and application of traditional Chinese medicine composition

Through the composition of sea cucumber, dogwood, lotus seeds and poria, α-glucosidase and α-amylase are effectively inhibited, solving the problem of insufficient side effects and inhibition rate of existing drugs, and achieving efficient antioxidant and antidiabetic effects , suitable for food and health products.

CN118924808APending Publication Date: 2024-11-12NANJING UNIV OF TRADITIONAL CHINESE MEDICINE +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411048368.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing α-glucosidase inhibitors and α-amylase inhibitors have side effects when used, and the single Chinese medicinal material or its extracts do not have enough inhibition on the enzyme, so it cannot effectively control blood sugar levels.

Method used

Using sea cucumber, dogwood, lotus seeds and poria cocos, extracts its active ingredients through decoction, and prepares a traditional Chinese medicine composition that can effectively inhibit α-glucosidase and α-amylase, combining various ingredients. Synergistically act to achieve effective inhibition of enzymes.

Benefits of technology

It achieves a 100% inhibition rate of α-glucosidase and α-amylase, significantly improves the antioxidant and anti-diabetic effects, and has low toxic side effects. It is suitable for food and health products, and is easy to produce.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924808A_ABST
    Figure CN118924808A_ABST
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition for resisting oxidation and assisting in reducing blood sugar as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following components in parts by mass: 3 to 9 parts of sea cucumber, 6 to 24 parts of fructus corni, 12 to 36 parts of lotus seed with core and 5 to 15 parts of poria cocos. The traditional Chinese medicine composition has an extremely strong effect of inhibiting alpha-amylase and alpha-glucosidase, so that an extremely good anti-oxidation and / or anti-diabetes effect is achieved, the preparation method is simple and convenient, large-scale production is easy, and when the traditional Chinese medicine composition is applied to preparation of anti-oxidation and / or anti-diabetes medicines, the curative effect is good, and toxic and side effects are avoided; and when being applied to food or health-care products, the compound has strong palatability, is convenient for patients to accept and has great application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a Chinese medicine composition, in particular to an anti-oxidation and blood sugar lowering Chinese medicine composition, and also to a preparation method and application of the Chinese medicine composition. Background Art

[0002] In contemporary society, people often face various environmental and life pressures, as well as unhealthy lifestyles, which may trigger oxidative stress responses in the body. Oxidative stress is a key factor in the development of many chronic diseases, including but not limited to diabetes. The role of antioxidants in the treatment of diabetes is increasingly valued. In an environment of long-term hyperglycemia infiltration, diabetic patients have metabolic disorders that affect the activity and expression of various antioxidant enzymes that scavenge free radicals, so that free radicals cannot be cleared in time and accumulate in tissue cells. By regulating and improving the oxidative stress state in diabetic patients, inhibiting or reversing the damaging effects of free radicals on tissue cells, it can play a positive role in preventing and treating the progression of diabetes.

[0003] The treatment principles of diabetes include changing lifestyle (including diet control, physical exercise, weight management, smoking cessation and avoiding secondhand smoke, etc.), combined with drug therapy, to achieve blood sugar control, delay disease progression or deterioration, and prolong drug treatment time, thereby preventing complications. Postprandial hyperglycemia is one of the pathogenesis of type 2 diabetes and an important factor causing vascular complications. α-Glucosidase is a key target for delaying postprandial blood sugar increase. α-Glucosidase inhibitors are a class of drugs commonly used in the treatment of diabetes. They mainly inhibit the activity of α-glucosidase in the intestine and slow down the degradation rate of glucose in the intestine, thereby delaying the absorption of glucose. α-Amylase is a glycoside hydrolase that has a hydrolysis and digestion effect on the main carbohydrates in food. The activity of salivary pancreatic amylase in the gastrointestinal tract can be effectively inhibited by α-amylase inhibitors, which reduces the decomposition and absorption of starch sugars, inhibits the increase in blood sugar concentration, plays a role in lowering blood sugar, and is beneficial to the dietary treatment of diabetic patients; according to a large number of studies, inhibition of α-amylase and α-glucosidase is considered to be one of the most effective methods for the treatment of diabetes. The use of these medications helps control blood sugar levels and is an important strategy in diabetes management.

[0004] There are relatively few types of α-glucosidase inhibitors and α-amylase inhibitors on the market, including only three types: acarbose, voglibose and miglitol. They all have good effects on regulating blood sugar, but are often accompanied by various side effects and adverse reactions when used, and are not accepted by all people. For example, it is reported that acarbose can cause adverse reactions such as abdominal distension, diarrhea and abdominal pain, arrhythmia, rash, and long-term use may even cause serious liver damage. The side effects of acarbose mainly come from its excessive inhibition of α-amylase. At the same time, there are also developments in the field of traditional Chinese medicine for the purpose of inhibiting enzyme activity. For example, the total flavonoid extract of lotus seed heart has an inhibition rate of only 30.5% on α-glucosidase when used alone at a maximum concentration of 10 mg / ml (Li Qiuzhe. Structural analysis of flavonoids in lotus seed heart and research on their hypoglycemic activity [D]. Fujian Agriculture and Forestry University, 2015.) A compound was isolated from the boiled liquid of sea cucumber, and its IC50 value for inhibiting α-glucosidase was 34.6 mg / mL (Ding Jianjun, Yang Jie, Jiang Shan, et al. Isolation of α-glucosidase activity inhibitory components in sea cucumber boiled liquid [J]. Industry and Technology Forum, 2011 (2): 2. DOI: 10.3969 / j.issn.1673-5641.2011.02.042.) Therefore, the existing traditional Chinese medicine or its extract has an inhibition rate of only 30% on a single enzyme, which is not effective. Therefore, in order to improve the patient's medication experience and improve the treatment effect, it is necessary to develop new enzyme inhibitor drugs. Summary of the invention

[0005] Purpose of the invention: The purpose of the present invention is to provide a Chinese medicine composition for antioxidant and auxiliary hypoglycemic effect which can effectively inhibit the activities of α-glucosidase and α-amylase, and also provides a preparation method and application of the above Chinese medicine composition.

[0006] Technical solution: The present invention discloses an antioxidant and blood sugar-lowering Chinese medicine composition, comprising the following components in parts by weight: 3-9 parts of sea cucumber, 6-24 parts of cornus officinalis, 12-36 parts of lotus seeds with cores and 5-15 parts of Poria cocos.

[0007] The Chinese medicine composition comprises the following components in parts by weight: 5-7 parts of sea cucumber, 10-14 parts of cornus officinalis, 20-28 parts of lotus seeds with cores and 9-10 parts of Poria cocos, preferably 6 parts of sea cucumber, 12 parts of cornus officinalis, 24 parts of lotus seeds with cores and 9.6 parts of Poria cocos.

[0008] The preparation method of the above-mentioned Chinese medicine composition comprises the following steps:

[0009] (1) Take sea cucumber, cornus officinalis, lotus seeds with core and Poria cocos, soak them in water, and boil them; filter the mixture, and cool the filtrate at room temperature to obtain a decoction;

[0010] (2) Take the above decoction, centrifuge it and take the supernatant.

[0011] Among them, step (1) specifically comprises taking sea cucumber, cornus officinalis, lotus seeds with core and poria cocos, adding 2 to 6 times the amount of water and soaking them for 0.5 to 1 hour, boiling them, maintaining a slight boil for 45 minutes to 1 hour, filtering them while hot, and cooling the filtrate at room temperature to obtain a water decoction.

[0012] Wherein, in step (2), the centrifugation is carried out at 4000-4500G and room temperature for 15-20 minutes.

[0013] The invention also discloses the use of the traditional Chinese medicine composition in preparing anti-oxidation and / or anti-diabetic drugs.

[0014] Wherein, the Chinese medicine composition achieves anti-oxidation and / or anti-diabetic effects by inhibiting α-amylase and α-glucosidase.

[0015] The Chinese medicine composition can also be applied to food or health products. Specifically, a small amount of the medicine composition is added to food, such as broth or meals.

[0016] Furthermore, the Chinese medicine composition is applied to food and is suitable for preparing duck soup or turtle soup.

[0017] Specifically: fresh (frozen) paddy duck meat is used as the main raw material, with sea cucumber, morel, Euryale ferox, coix seed, red dates, walnut kernel, longan, wolfberry, lotus seed, yam, Alpinia oxyphylla, raspberry, kudzu root, Poria cocos, hawthorn, edible salt, edible vegetable oil, chicken seasoning, monosodium glutamate, food additive xylitol, sodium D-isoascorbate, with or without one or more of polygonatum, cinnamon, ginseng (artificially cultivated), angelica, galangal, saffron (saffron), tsaoko, turmeric, longan, codonopsis, meat Rong (desert), dendrobium officinale, American ginseng, astragalus, ganoderma lucidum, cornus officinalis, gastrodia elata, eucommia leaf, and the duck soup pot is made through pretreatment, batching, braising, cooling, canning with Nongfu Spring drinking natural water, sterilization, and cooling;

[0018] Or the turtle soup is made by using Chinese soft-shelled turtle (terrapin) as the raw material, slaughtering, processing, and pickling, and adding Nongfu Spring drinking natural water, soy sauce, edible salt, monosodium glutamate, star anise, rice wine, onion, ginger, pepper, cinnamon, edible vegetable oil, food additives (xylitol, sodium D-isoascorbate), or not adding one or more of ginseng (artificially cultivated), wolfberry, shiitake mushrooms, chicken feet, red dates, angelica, galangal, saffron, amomum villosum, turmeric, piper longum, codonopsis, rongrong (desert), dendrobium officinale, American ginseng, astragalus, ganoderma lucidum, yew lily, gastrodia elata, and eucommia leaves, and canning, heating and sterilizing, and cooling.

[0019] Principle of the invention: The Chinese medicine composition of the present invention can simultaneously and efficiently inhibit α-glucosidase and α-amylase, and further treat and protect diabetes while exerting an antioxidant effect, thus solving the serious defects of existing clinical drug applications.

[0020] The composition of the present invention contains multiple active ingredients, such as polysaccharides in cornus officinalis, flavonoid components of lotus seeds, triterpenes in Poria cocos, saponin components in sea cucumbers, etc., which can act on different active sites of enzymes in a complementary manner, thereby enhancing the overall inhibitory effect, achieving the inhibitory effect on α-glucosidase and α-amylase; and can specifically achieve the effect that the inhibitory effect on α-amylase is weaker than the inhibitory effect on α-glucosidase, avoiding the adverse reactions caused by excessive inhibition of α-amylase. The present invention combines sea cucumber, cornus officinalis, cored lotus seeds and Poria cocos, and studies the optimal ratio of the combination, achieving the effect of simultaneously achieving efficient inhibition of α-glucosidase and α-amylase activity, and the drug efficacy is far better than the simple superposition of each component used alone or several components used in combination, and the inhibition rate is as high as 100% at the maximum concentration, with significant synergistic effect.

[0021] At the same time, the four raw materials of the composition are all pure natural Chinese medicines with low toxic and side effects, less harm to the human body, easy to produce, economical and practical; from the perspective of traditional Chinese medicine, sea cucumber has the function of nourishing yin, cornus officinalis has the function of nourishing the kidney and consolidating the body, and lotus seeds and poria have the function of nourishing the spleen and nourishing the stomach. The combination of these medicines has the functions of nourishing yin and moistening dryness, regulating the spleen and stomach, and nourishing the liver and kidneys, and can be used to improve the symptoms of kidney yin deficiency and spleen and stomach disharmony in diabetic patients, and is helpful to regulate the overall physical condition of diabetic patients; and the inhibitory effect of the Chinese medicinal ingredients in the composition of the present invention on α-glucosidase and α-amylase is a non-competitive inhibition type, which means that these ingredients can combine with the substrate of the enzyme at the same time, rather than just blocking the combination of the enzyme and the substrate, so that these ingredients produce a more lasting and extensive inhibitory effect in the body.

[0022] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: (1) The Chinese medicine composition of the present invention has a very strong effect of inhibiting α-amylase and α-glucosidase, thereby achieving an excellent antioxidant and / or anti-diabetic effect. The inhibition rate is as high as 100% at the maximum concentration, and the inhibitory effect is more lasting and extensive; (2) The preparation method is simple and easy to mass produce; (3) When used in the preparation of antioxidant and / or anti-diabetic drugs, it has good efficacy and no toxic side effects; when used in food or health products, it has strong palatability and is easy for patients to accept. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is to verify the free radical scavenging ability of the Chinese medicine composition of the present invention, wherein A is an ABTS free radical, B is a DPPH free radical, and C is a hydroxyl free radical;

[0024] Figure 2 The Chinese medicine composition of the present invention has an inhibitory effect on α-glucosidase;

[0025] Figure 3 The Chinese medicine composition of the present invention has an inhibitory effect on α-amylase;

[0026] Figure 4 The inhibitory effect of comparative example 1 on α-glucosidase;

[0027] Figure 5 The inhibitory effect of comparative example 2 on α-glucosidase activity;

[0028] Figure 6 This is the inhibitory effect of Comparative Example 2 on the activity of α-amylase. DETAILED DESCRIPTION

[0029] The technical scheme of the present invention is further described below in conjunction with the examples. The test materials used in the examples can all be purchased through conventional channels.

[0030] The components of the Chinese medicine composition are: sea cucumber (soaked in water), cornus officinalis, lotus seeds (with core) and poria cocos.

[0031] Main reagents:

[0032] Table 1. Experimental reagents

[0033]

[0034] Example 1

[0035] The traditional Chinese medicine composition of the present invention comprises the following components in parts by weight: 6 parts of sea cucumber, 12 parts of cornus officinalis, 24 parts of lotus seeds with cores and 9.6 parts of poria cocos.

[0036] Preparation method: Take 6g of sea cucumber, 12g of cornus officinalis, 24g of lotus seeds (with core) and 9.6g of Poria cocos, add 200mL of water and soak for 0.5h, boil, keep slightly boiling for 45min, filter with non-woven fabric while hot, let the filtrate cool at room temperature, and dilute to 200mL with water. Take 100mL of the above decoction, centrifuge at 4,000G and 25℃ for 15min, and take the supernatant for later use.

[0037] Example 2

[0038] The traditional Chinese medicine composition of the present invention comprises the following components in parts by weight: 5 parts of sea cucumber, 14 parts of cornus officinalis, 28 parts of lotus seeds with cores and 15 parts of poria cocos.

[0039] Preparation method: Take 5g of sea cucumber, 14g of cornus officinalis, 28g of lotus seeds (with core) and 15g of Poria cocos, add 200mL of water and soak for 0.5h, boil, keep slightly boiling for 45min, filter with 6 layers of gauze while hot, let the filtrate cool at room temperature, and dilute to 200mL with water. Take 100mL of the above decoction, centrifuge at 4,000G and 25℃ for 15min, and take the supernatant for later use.

[0040] Example 3

[0041] The traditional Chinese medicine composition of the present invention comprises the following components in parts by weight: 7 parts of sea cucumber, 10 parts of cornus officinalis, 20 parts of lotus seeds with cores and 5 parts of poria cocos.

[0042] Preparation method: Take 7g of sea cucumber, 10g of cornus officinalis, 20g of lotus seeds (with core) and 5g of Poria cocos, add 200mL of water and soak for 0.5h, boil, keep slightly boiling for 45min, filter with 6 layers of gauze while hot, let the filtrate cool at room temperature, and dilute to 200mL with water. Take 100mL of the above decoction, centrifuge at 4,000G and 25℃ for 15min, and take the supernatant for later use.

[0043] Comparative Example 1

[0044] A Chinese medicine composition, compared with Example 1, adds astragalus, and includes the following components in parts by weight: 6 parts of sea cucumber, 12 parts of cornus officinalis, 24 parts of lotus seeds with cores, 9.6 parts of Poria cocos, and 7 parts of astragalus.

[0045] Preparation method: Take 6g of sea cucumber, 12g of cornus officinalis, 24g of lotus seeds (with core), 9.6g of Poria cocos, and 7g of Astragalus membranaceus, add 200mL of water and soak for 0.5h, boil, keep slightly boiling for 45min, filter with 6 layers of gauze while hot, let the filtrate cool at room temperature, and dilute to 200mL with water. Take 100mL of the above decoction, centrifuge at 4,000G and 25℃ for 15min, and take the supernatant for later use.

[0046] Comparative Example 2

[0047] A Chinese medicine composition, compared with Example 1, replaces sea cucumber with astragalus, and includes the following components in parts by weight: 12 parts of Cornus officinalis, 24 parts of lotus seeds with core, 9.6 parts of Poria cocos, and 7 parts of Astragalus.

[0048] Preparation method: Take 12g of Cornus officinalis, 24g of lotus seeds (with core), 9.6g of Poria cocos, and 7g of Astragalus membranaceus, add 200mL of water and soak for 0.5h, boil, keep it slightly boiling for 45min, filter it with 6 layers of gauze while it is hot, let the filtrate cool at room temperature, and dilute it to 200mL with water. Take 100mL of the above decoction, centrifuge it at 4,000G and 25℃ for 15min, and take the supernatant for later use.

[0049] The ABTS free radical scavenging ability of the Chinese medicine composition prepared in the example was verified:

[0050] ABTS [Diammonium 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate, i.e. 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonate) diammonium salt] can be oxidized by a series of compounds such as potassium persulfate (KPS, K2S2O8), hydrogen peroxide, and manganese dioxide to generate blue-green ABTS + Cationic free radicals have an absorption peak at 734nm; under the action of antioxidants, ABTS + Reduced to colorless ABTS. The antioxidant capacity of the reactant can be determined by measuring the absorbance at 734nm, which is expressed by the free radical scavenging rate (SR). The greater the scavenging rate, the stronger the antioxidant capacity.

[0051] The specific operation is as follows: weigh 38.3 mg of ABTS powder in a dark place, add water to dissolve and make up to 10 mL to obtain a 7 mmol / L ABTS solution; weigh 6.7 mg of KPS, add water to dissolve and make up to 10 mL to obtain a 2.45 mmol / L KPS solution; mix the above ABTS solution and KPS solution in a volume ratio of 1:1, as the working base solution, and store for 12 to 16 hours in a dark place. Dilute the ABTS working base solution with methanol, and measure its absorbance at 734 nm, so that the value is controlled between 30% and 70% of the instrument's measurement range, and the ABTS free radical working solution is obtained. The amount of ABTS free radical scavenging experimental reagents added is shown in Table 2.

[0052] Table 2. Sample volume of ABTS free radical scavenging test reagent (μL)

[0053]

[0054] “*” indicates that the sample was replaced with water; “#” indicates that the ABTS was replaced with methanol.

[0055] (1)OD blank Measurement: Add 100 μL of water and 100 μL of ABTS working solution to a 96-well plate, mix well, and mix at room temperature for 15 min in the dark. Measure the absorbance (OD) at 734 nm and record it as OD blank .

[0056] (2)OD sample Measurement: Replace water with a Chinese herbal medicine composition (or positive drug rutin) of different gradient concentrations, and the measured absorbance value is recorded as OD sample. According to preliminary tests, the concentration gradient of the Chinese medicine composition (calculated according to the crude drug content) is: 0.0129 mg / mL, 0.129 mg / mL, 1.29 mg / mL, 12.9 mg / mL, 129 mg / mL; the concentration gradient of rutin is: 0.125 μg / mL, 1.25 μg / mL, 12.5 μg / mL, 125 μg / mL and 1250 μg / mL.

[0057] (3)OD control Measurement: Take 100 μL of the Chinese medicine composition (or positive drug rutin) with different gradient concentrations and 100 μL of water, add them to the wells of a 96-well plate, mix them thoroughly, and perform the same operation. The measured absorbance value is recorded as OD control .

[0058] (4) Calculation formula: Calculate the ABTS free radical scavenging capacity and EC of the sample according to formula 1. 50 :

[0059] ABTS free radical

[0060] The DPPH free radical scavenging ability of the Chinese medicine composition prepared in the example was verified:

[0061] In the DPPH [1,1-Diphenyl-2-picrylhydrazyl radical] molecule, due to the presence of multiple electron-withdrawing -NO2 and the large π bond of the benzene ring, the nitrogen free radical can exist stably. As a stable free radical, DPPH's methanol solution is purple, and its maximum absorption peak in the visible light region is 519nm. When a free radical scavenger is added to the DPPH solution, the solution color becomes lighter, and its absorbance at 519nm becomes smaller, and the degree of absorbance reduction is linearly related to the degree of free radical scavenging.

[0062] Weigh about 24.6 mg of DPPH in a dark place, add methanol and make it constant to 10 mL to obtain 6.2 mmol / L DPPH working base solution. Dilute the DPPH working base solution with methanol and measure its absorbance at 519 nm to control the value between 30% and 70% of the instrument's measurement range to obtain the DPPH free radical working solution. The amount of DPPH free radical scavenging experimental reagents added is shown in Table 3.

[0063] Table 3. Sample volume of DPPH free radical scavenging test reagent (μL)

[0064]

[0065] “*” indicates that the sample was replaced with water; “#” indicates that the DPPH was replaced with methanol.

[0066] (1)OD blank Measurement: Add 100 μL of water and 100 μL of DPPH working solution to a 96-well plate, mix well, and mix at room temperature for 30 min in the dark. Measure the absorbance (OD) at 519 nm and record it as OD blank .

[0067] (2)OD sample Measurement: Replace water with a Chinese herbal medicine composition (or positive drug rutin) of different gradient concentrations, and the measured absorbance value is recorded as OD sample . According to preliminary tests, the concentration gradient of the Chinese medicine composition (calculated according to the crude drug content) is: 0.2064 mg / mL, 1.032 mg / mL, 5.16 mg / mL, 25.8 mg / mL, 129 mg / mL; the concentration gradient of rutin is: 0.25 μg / mL, 2.5 μg / mL, 25 μg / mL, 250 μg / mL and 2500 μg / mL.

[0068] (3)OD control Measurement: Take 100 μL of the Chinese medicine composition (or positive drug rutin) with different gradient concentrations and 100 μL of water, add them to the wells of a 96-well plate, mix them thoroughly, and perform the same operation. The measured absorbance value is recorded as OD control .

[0069] (4) Calculation formula: Calculate the DPPH free radical scavenging capacity and EC of the sample according to formula 2 50 :

[0070] DPPH free radical

[0071] The hydroxyl radical scavenging ability of the Chinese medicine composition prepared in the example was verified:

[0072] Hydroxyl free radical scavenging activity is another important indicator for measuring the antioxidant capacity of a substance. Its determination principle is: using the Fenton reaction to generate hydroxyl free radicals: FeSO4 aqueous solution 2+ Oxidized to Fe 3+ A large number of hydroxyl radicals (·OH) are generated. The hydroxyl radicals generated by the reaction are captured by salicylic acid in the system to produce purple compounds with a maximum absorption peak at 510nm. The absorbance is proportional to the content of hydroxyl radicals. If the sample solution has a good hydroxyl radical scavenging ability, the generation of colored substances will be reduced.

[0073] Weigh 83.4 mg of FeSO4·7H2O, add 1 mL of 10% sulfuric acid to dissolve, and add water to make up to 10 mL as the mother solution (colorless). Dilute 10 times with water before use (3mmol / L); Hydrogen peroxide solution (3mmol / L): measure 340 mL of 3% H2O2, dilute with water and make up to 10 mL as the mother solution. Dilute 10 times with water before use (3mmol / L); Salicylic acid solution (6mmol / L): weigh 83 mg of salicylic acid, add 1 mL of DMSO to dissolve, and add water to make up to 10 mL as the mother solution. Dilute 10 times with water before use (6mmol / L). The amount of hydroxyl radical scavenging test reagents is shown in Table 4.

[0074] Table 4. Sample volume of hydroxyl radical scavenging test reagent (μL)

[0075]

[0076] “*” indicates that the sample was replaced with water in the same amount.

[0077] (1)OD blank Measurement: 50 μL of water, ferrous sulfate solution (3 mmol / L) and hydrogen peroxide solution (3 mmol / L) were added to the wells of a 96-well plate and mixed for 10 min; then 50 μL of salicylic acid solution (6 mmol / L) was added and cultured in the dark for 30 min. The absorbance (OD) was measured at a wavelength of 510 nm and recorded as OD blank .

[0078] (2)OD sample Measurement: The absorbance value measured was recorded as OD after replacing water with a Chinese medicine composition of different gradient concentrations. sample . Preliminary experiments determined that the concentration gradient of the Chinese medicine composition (calculated based on the crude drug content) was: 0.2064 mg / mL, 1.032 mg / mL, 5.16 mg / mL, 25.8 mg / mL, 129 mg / mL; the concentration gradient of rutin was: 0.125 μg / mL, 1.25 μg / mL, 12.5 μg / mL, 125 μg / mL and 1250 μg / mL.

[0079] (3)OD control Measurement: Take 50 μL of the Chinese medicine composition with different gradient concentrations, 50 μL of ferrous sulfate solution (3 mmol / L) and water (instead of salicylic acid) and mix and incubate for 10 minutes; then add 50 μL of hydrogen peroxide solution, incubate in the dark for 30 minutes, and measure the absorbance (OD). The measured absorbance value is recorded as OD control .

[0080] (4) Calculation formula: Calculate the hydroxyl radical scavenging capacity and EC of the sample according to formula 3. 50:

[0081] Hydroxyl radical

[0082] The experimental results of the above-mentioned free radical scavenging ability are as follows: From the color change after the reaction, ① after the oxidation reaction of ABTS and potassium persulfate, a significant color change was observed, producing blue-green ABTS + ② After the Chinese medicine composition reacts with DPPH, the color of the ABTS radical working solution gradually fades, showing its effective scavenging of ABTS radicals. ② After the Chinese medicine composition reacts with DPPH, it changes from purple (the color of DPPH itself) to light yellow. ③ In the hydroxyl radical scavenging experiment, a large amount of ·OH produced by the Fenton reaction reacts with salicylic acid to turn purple; and after reacting with the Chinese medicine composition, the purple gradually becomes lighter.

[0083] From the analysis results of antioxidant assay data, Figure 1 As shown, the Chinese medicine composition in Example 1 showed certain scavenging ability against the three free radicals: ① ABTS free radical scavenging rate (%) EC 50 is (7.527±0.327) mg / mL; while the EC of the positive drug rutin 50 (9.411±0.731)μg / mL( Figure 1 (A) ② DPPH free radical scavenging rate (%) EC 50 is (22.42±1.42)mg / mL; while the EC of positive drug rutin 50 (7.718±0.600)μg / mL( Figure 1 (B) ③ EC of hydroxyl radical scavenging rate (%) 50 is (15.71±0.70)mg / mL; while the EC of positive drug rutin 50 (67.39±14)μg / mL( Figure 1 C). It can be seen that the Chinese medicine composition of the present invention has high antioxidant activity against the three free radicals, among which ABTS free radical scavenging rate is the highest.

[0084] Table 1, Examples 1 to 3 on DPPH free radical scavenging effect

[0085]

[0086] The ability of the Chinese medicine composition prepared in the example to inhibit the activity of α-glucosidase was verified:

[0087] pNPG (p-nitrophenol-α-D-glucopyranoside, i.e. p-nitrophenol-α-D-glucoside) is a reaction substrate, which is originally colorless. After being hydrolyzed by α-glucosidase, p-nitrophenol (pNP) is released. pNP is yellow under alkaline conditions, and its maximum absorption peak in the visible light region is 405nm. When an α-glucosidase inhibitor is added to the reaction solution, the color of the solution becomes lighter, and its absorbance at 405nm becomes smaller, and the degree of absorbance reduction is linearly related to the degree of inhibition of α-glucosidase. Therefore, the inhibition rate of the sample on α-glucosidase can be calculated by measuring the absorbance here.

[0088] Weigh 3 mg of α-glucosidase (33.7 U / mg) lyophilized powder, dissolve it in PBS buffer (pH 7.4) and dilute it to 0.8 mL as a mother solution (125 U / mL). Dilute it to 100 times with PBS before use (1.25 U / mL); weigh 75.3 mg of pNPG, dissolve it in PBS buffer (pH 7.4) and dilute it to 10 mL as a mother solution (25 mmol / L). Dilute it to 10 times with PBS before use (2.5 mmol / L); weigh 10.6 g of Na2CO3, dissolve it in water and dilute it to 100 mL (1 mol / L). The amount of reagents added for the α-glucosidase activity inhibition experiment is shown in Table 5.

[0089] Table 5. Sample volume of α-glucosidase activity inhibition test reagent (μL)

[0090]

[0091]

[0092] “*” indicates that the solution was replaced by water in the same amount as the sample; “#” indicates that the solution was replaced by PBS in the same amount as the enzyme.

[0093] (1)OD blank : 50 μL of PBS (pH 7.4), 10 μL of water and 20 μL of 1.25 U / mL α-glucosidase solution were added to a 96-well plate, mixed, and incubated at 37°C for 20 min; 20 μL of 2.5 mmol / L pNPG solution was added, mixed, and the reaction was continued at 37°C for 40 min, and then 100 μL of 1 mol / L Na2CO3 solution was added to terminate the reaction, and the absorbance (OD) was measured at a wavelength of 405 nm, which was recorded as OD blank .

[0094] (2)OD sample:After replacing water with a Chinese medicine composition of different gradient concentrations, the operation is performed, and then from "adding 2.5mmol / L pNPG solution" to "measuring the absorbance at a wavelength of 405nm", the measured absorbance value is recorded as OD sample . According to preliminary tests, the concentration gradient of the Chinese medicine composition (calculated according to the crude drug content) is: 4μg / mL, 20μg / mL, 100μg / mL, 500μg / mL, 2500μg / mL.

[0095] (3)OD zero : Take 70 μL of PBS (20 μL of PBS replaces α-glucosidase solution) and 10 μL of water, add them to the wells of the 96-well plate, mix them thoroughly, and then measure the absorbance from "add 2.5 mmol / L pNPG solution" to "measure the absorbance at a wavelength of 405 nm". The measured absorbance value is recorded as OD zero .

[0096] (4)OD control : Take 70 μL of PBS (20 μL of PBS replaces α-glucosidase solution) and 10 μL of the Chinese medicine composition with the same gradient concentration, mix them, and then measure the absorbance from "adding 2.5 mmol / L pNPG solution" to "measuring the absorbance at a wavelength of 405 nm". The measured absorbance value is recorded as OD control .

[0097] (5) Calculation formula: Calculate the inhibition rate and IC of the sample on α-glucosidase according to formula 4 50 :

[0098]

[0099] The pNPG method was used to determine the activity of α-glucosidase. From the color change after the reaction, pNPG turned yellow under alkaline conditions after being hydrolyzed by α-glucosidase. When the Chinese medicine composition was added to the reaction solution, the color of the solution became lighter, indicating that it contained α-glucosidase inhibitors. From the data of its absorbance measurement at 405nm, it was found that as the concentration of the decoction of the medicinal food components increased, the absorption of the reaction solution decreased significantly, revealing that the Chinese medicine composition has the effect of inhibiting the activity of α-glucosidase. Figure 2 As shown, the inhibition rate of the Chinese medicine composition on α-glucosidase is IC50=427.8 (372.1-491.4) μg / mL.

[0100] Compared with Comparative Example 1, by adding Astragalus to change the components, a composition outside the scope of the present application was prepared and its inhibitory effect on α-glucosidase activity was verified. It was found that its IC50 for α-glucosidase activity was 746.6 mg / ml ( Figure 4), which is far inferior to the effect of Example 1. This proves the superiority of the combination of Example 1.

[0101] Compared with Comparative Example 2, by replacing the sea cucumber component, a composition outside the scope of the present application was prepared and its inhibitory effect on α-glucosidase activity was verified. It was found that its IC50 for α-glucosidase activity was 2.457 mg / ml ( Figure 5 ), which is far inferior to the effect of Example 1. This proves the superiority of the combination of Example 1.

[0102] The ability of the Chinese medicine composition prepared in the example to inhibit the activity of α-amylase was verified:

[0103] α-amylase catalyzes the decomposition of substrate starch to produce glucose, maltose and α-1,6 glycosidic bond branched dextrin, while the residual starch that is not decomposed by the enzyme reacts with the iodine reagent to form a blue complex. The reaction is carried out on a 96-well plate, and the maximum absorption peak of the iodine-starch blue complex in the visible light region is at 600nm. When an α-amylase inhibitor is added to the reaction solution, the activity of α-amylase is inhibited, reducing the hydrolysis of starch, and the absorbance measured at 600nm will increase, and there is a dose-effect relationship. Therefore, the inhibition rate of the sample on α-amylase can be calculated by measuring the absorbance here.

[0104] Weigh 20 mg of α-amylase (35 U / mg) freeze-dried powder, add PBS buffer (pH 6.9) to dissolve and dilute to 100 mL (7 U / mL); weigh 0.5 g of soluble starch, add a small amount of distilled water to dissolve to form a suspension, place in a magnetic stirrer and slowly add boiling water to boil until clear and transparent, cool, and dilute to 100 ml (0.5%); weigh 1.27 g of iodine and 2.5 g of potassium iodide, add a small amount of distilled water to dissolve, dilute to 100 mL of mother solution (0.1 mol / l), and dilute 100 times (1 mmol / L) when used. The amount of reagents added for the inhibition of α-amylase activity experiment is shown in Table 6.

[0105] Table 6. Sample volume of α-amylase inhibition test reagent (μL)

[0106]

[0107] “*” indicates that the solution was replaced by water in the same amount as the sample; “#” indicates that the solution was replaced by PBS in the same amount as the enzyme.

[0108] (1)OD blank: Add 50 μL of water and 25 μL of 7U / mL α-amylase solution to a 96-well plate, mix well, and incubate at 37°C for 10 min; add 25 μL of 0.5% soluble starch solution, mix well, and continue to react at 37°C for 10 min, then add 40 μL of 0.5% hydrochloric acid to terminate the reaction, add 1 mmol / L iodine solution for color development, and measure the absorbance (OD) at a wavelength of 600 nm, which is recorded as OD blank .

[0109] (2)OD sample :After replacing water with a Chinese medicine composition of different gradient concentrations, the operation is performed, and then from "adding 0.5% soluble starch solution" to "measuring absorbance at a wavelength of 600nm", the measured absorbance value is recorded as OD sample . According to preliminary tests, the concentration gradient of the Chinese medicine composition (calculated based on the crude drug content) is: 0.08 mg / mL, 0.4 mg / mL, 2 mg / mL, 10 mg / mL, 50 mg / mL.

[0110] (3)OD zero : Add 50 μL of water and 25 μL of PBS solution (replacing the above 25 μL of enzyme solution) to a 96-well plate, mix well, and incubate at 37°C for 10 min; add 25 μL of 0.5% soluble starch solution, mix well, and continue to react at 37°C for 10 min, then add 40 μL of 0.5% hydrochloric acid to terminate the reaction, add 1 mmol / L iodine solution for color development, and measure the absorbance at a wavelength of 600 nm. The measured absorbance value is recorded as OD zero .

[0111] (4)OD control : Take 25 μL of PBS to replace the above enzyme solution and 50 μL of the Chinese medicine composition with the same gradient concentration, mix well, and then start from "add 25 μL of 0.5% soluble starch solution" until "measure the absorbance at a wavelength of 600 nm", and the measured absorbance value is recorded as OD control .

[0112] (5) Calculation formula: Calculate the inhibition rate and IC of the sample on α-amylase according to formula 5 50 :

[0113]

[0114] The iodine solution method was used to determine the activity of α-amylase. From the color change after the reaction, it can be seen that the starch turns blue after encountering the iodine solution, but the color becomes lighter when the starch is hydrolyzed by α-amylase and then reacts with the iodine solution; when the Chinese medicine composition is added to the reaction solution, the solution color becomes darker, indicating that it contains α-amylase inhibitors. From the data of the absorbance measurement at 600nm, it was found that as the concentration of the Chinese medicine composition increases, the absorption of the reaction solution increases significantly, revealing that the Chinese medicine composition has the effect of inhibiting the activity of α-amylase. Figure 3 As shown in the figure, the inhibitory rate of α-amylase by the decoction of medicinal diet components is IC 50 =379.6(347.7~414.6)μg / mL.

[0115] Compared with Comparative Example 2, by replacing the sea cucumber component, a composition outside the scope of the present application was prepared and its inhibitory effect on α-amylase activity was verified. It was found that its IC50 for inhibiting α-amylase activity was 177 mg / ml ( Figure 6 ), which is far inferior to the effect of the embodiment. This proves the superiority of the combination of the embodiment.

[0116] The above results show that the Chinese medicine composition of the present invention has good effects of lowering blood sugar and improving insulin resistance.

Claims

1. A Chinese medicine composition for anti-oxidation and assisting in lowering blood sugar, It is characterized in that The traditional Chinese medicine composition comprises the following components in parts by weight: 3-9 parts of sea cucumber, 6-24 parts of cornus officinalis, 12-36 parts of lotus seeds with cores and 5-15 parts of poria cocos.

2. The Chinese medicine composition according to claim 1, It is characterized in that The traditional Chinese medicine composition comprises the following components in parts by weight: 5-7 parts of sea cucumber, 10-14 parts of cornus officinalis, 20-28 parts of lotus seeds with cores and 9-10 parts of poria cocos.

3. A method for preparing the Chinese medicine composition according to claim 1, It is characterized in that The following steps are involved: (1) Take sea cucumber, cornus officinalis, lotus seeds with core and Poria cocos, soak them in water, and boil them; filter the mixture, and cool the filtrate at room temperature to obtain a decoction; (2) Take the above decoction, centrifuge it and take the supernatant.

4. The method according to claim 3, It is characterized in that Step (1) specifically comprises taking sea cucumber, cornus officinalis, lotus seeds with core and poria cocos, adding 2 to 6 times the amount of water and soaking them for 0.5 to 1 hour, boiling them, maintaining a slight boil for 45 minutes to 1 hour, filtering them while hot, and cooling the filtrate at room temperature to obtain a water decoction.

5. The method according to claim 3, It is characterized in that In step (2), the centrifugation is carried out at 4000-4500G and room temperature for 15-20 minutes.

6. Use of the traditional Chinese medicine composition according to claim 1 in the preparation of antioxidant and / or anti-diabetic drugs.

7. The use according to claim 6, It is characterized in that The traditional Chinese medicine composition achieves anti-oxidation and / or anti-diabetic effects by inhibiting α-amylase and α-glucosidase.

8. The use according to claim 6, It is characterized in that The Chinese medicine composition can also be applied to food or health products.